Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, and Nordrehaug JE (1995)
Failing to check for eligibility requirements based on the medication
It is created using solid phase peptide synthesis, which adds an additional tyrosine to the N-terminal
2015) and rats (Li et al
What many overlook: In CKD, the body cannot clear drugs properly Hypoglycemic agents stay longer Insulin breakdown is reduced Glucose production drops Result: Severe, sudden hypoglycemia What we changed: Stopped sulfonylurea immediately Switched to safer, renal-adjusted therapy Educated patient on diet + warning signs Clinical Reality Check: Sometimes, its not the disease Its the treatment that becomes dangerous
August 2023 Update: The first of what is expected to be many Ozempic and Mounjaro lawsuits was filed over gastroparesis side effects in the U.S